Imaging immunomodulatory treatment responses in a multiple sclerosis mouse model using hyperpolarized 13C metabolic MRI
Abstract Background In recent years, the ability of conventional magnetic resonance imaging (MRI), including T1 contrast-enhanced (CE) MRI, to monitor high-efficacy therapies and predict long-term disability in multiple sclerosis (MS) has been challenged. Therefore, non-invasive methods to improve M...
Main Authors: | Caroline Guglielmetti, Christian Cordano, Chloé Najac, Ari J. Green, Myriam M. Chaumeil |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-05-01
|
Series: | Communications Medicine |
Online Access: | https://doi.org/10.1038/s43856-023-00300-1 |
Similar Items
-
Imaging Neurodegenerative Metabolism in Amyotrophic Lateral Sclerosis with Hyperpolarized [1-<sup>13</sup>C]pyruvate MRI
by: Nikolaj Bøgh, et al.
Published: (2022-06-01) -
Metabolic phenotyping of prostate cancer using hyperpolarized 13C MRI
by: Deen, SS
Published: (2023) -
Hyperpolarized Carbon-13 MRI in Breast Cancer
by: Ramona Woitek, et al.
Published: (2023-07-01) -
13C MRI of hyperpolarized pyruvate at 120 µT
by: Nicolas Kempf, et al.
Published: (2024-02-01) -
Hyperpolarized 13C MRI: path to clinical translation in oncology
by: Kurhanewicz, J, et al.
Published: (2018)